|
|
![]() | ![]() | ![]() | ![]() |
| |||||||||
This excerpt taken from the SNTA 8-K filed Jun 15, 2009. Conference Call and Webcast Information
Synta will conduct a conference call to provide a corporate update today at 8:30 a.m. (ET). The conference call will be webcast live over the Internet and can be accessed by logging on to the Investors section of the Synta Pharmaceuticals website, www.syntapharma.com, prior to the event.
The call also can be accessed by dialing (877) 407-8035 or (201) 689-8035 prior to the start of the call. For those unable to join the live conference call, a replay will be available from 1:00 p.m. (ET) today through midnight (ET) on June 21. To access the replay, dial (877) 660-6853 or (201) 612-7415 and refer to both account number 286 and conference ID 325811. The webcast also will be archived on the Companys website.
This excerpt taken from the SNTA 8-K filed Feb 27, 2009. Conference Call and Webcast Information
Synta will conduct a conference call to discuss this announcement today at 5:30 p.m. (ET). The conference call will be webcast live over the Internet and can be accessed by logging on to the Investors section of the Synta Pharmaceuticals website, www.syntapharma.com, prior to the event.
The call also can be accessed by dialing (877) 407-8035 or (201) 689-8035 prior to the start of the call. For those unable to join the live conference call, a replay will be available from 10:00 p.m. (ET) today through midnight (ET) on March 5. To access the replay, dial (877) 660-6853 or (201) 612-7415 and refer to both account number 286 and conference ID 315337. The webcast also will be archived on the Companys website.
| EXCERPTS ON THIS PAGE:
|
| |||||||